Cargando…

Targeting HER2 in breast cancer: beyond trastuzumab

Detalles Bibliográficos
Autor principal: Winer, EP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247044/
http://dx.doi.org/10.1186/bcr3010
_version_ 1782220030952341504
author Winer, EP
author_facet Winer, EP
author_sort Winer, EP
collection PubMed
description
format Online
Article
Text
id pubmed-3247044
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32470442011-12-29 Targeting HER2 in breast cancer: beyond trastuzumab Winer, EP Breast Cancer Res Oral Presentation BioMed Central 2011 2011-11-16 /pmc/articles/PMC3247044/ http://dx.doi.org/10.1186/bcr3010 Text en Copyright ©2011 Winer.
spellingShingle Oral Presentation
Winer, EP
Targeting HER2 in breast cancer: beyond trastuzumab
title Targeting HER2 in breast cancer: beyond trastuzumab
title_full Targeting HER2 in breast cancer: beyond trastuzumab
title_fullStr Targeting HER2 in breast cancer: beyond trastuzumab
title_full_unstemmed Targeting HER2 in breast cancer: beyond trastuzumab
title_short Targeting HER2 in breast cancer: beyond trastuzumab
title_sort targeting her2 in breast cancer: beyond trastuzumab
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247044/
http://dx.doi.org/10.1186/bcr3010
work_keys_str_mv AT winerep targetingher2inbreastcancerbeyondtrastuzumab